[ALNY] YoY Annual Result on 31-Dec-2013 [#FY]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
20-Feb-2014
Financial Year
2013
Quarter
31-Dec-2013 [#FY]
Profit Trend
YoY- 15.84%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Annual Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 47,159 41,097 50,561 47,167 66,725 82,757 100,041 -11.77%
PBT -410,108 -290,073 -400,604 -91,920 -116,586 -57,649 -43,001 45.57%
Tax -23,438 -24,909 -40,209 -2,695 -10,572 -5,799 514 -
NP -410,108 -290,073 -360,395 -89,225 -106,014 -57,649 -43,515 45.28%
Tax Rate - - - - - - - -
Total Cost 457,267 331,170 410,956 136,392 172,739 140,406 143,556 21.27%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -869.63 -705.83 -712.79 -189.17 -158.88 -69.66 -43.50 64.66%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -4.79 -3.45 -4.85 -1.45 -2.11 -1.36 -1.04 28.95%
EPS Diluted -4.79 -3.45 -4.85 -1.45 -2.11 -1.36 -1.04 28.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.